نتائج البحث - "Meier, Juris J."

1

دورية أكاديمية

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes

المؤلفون: Aroda, Vanita R., Erhan, Umut, Jelnes, Peter, Meier, Juris J., Abildlund, Morten Tind, Pratley, Richard, Vilsbøll, Tina, Husain, Mansoor

المصدر: Aroda , V R , Erhan , U , Jelnes , P , Meier , J J , Abildlund , M T , Pratley , R , Vilsbøll , T & Husain , M 2023 , ' Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 5 , pp. 1385-1397 . https://doi.org/10.1111/dom.14990Test

مصطلحات موضوعية: antidiabetic drug, GLP-1, phase III study, randomized trial, type 2 diabetes

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1111/dom.14990Test
https://curis.ku.dk/portal/da/publications/safety-and-tolerability-of-semaglutide-across-the-sustain-and-pioneer-phase-iiia-clinical-trial-programmesTest(6dfb69dc-bb75-47b4-9dee-55ea56059d8f).html
https://curis.ku.dk/ws/files/365703618/Diabetes_Obesity_Metabolism_2023_Aroda.pdfTest

View record in BASE

2

دورية أكاديمية

The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.

المؤلفون: Gasbjerg, Lærke S., Rosenkilde, Mette M., Meier, Juris J., Holst, Jens J., Knop, Filip K.

المصدر: Diabetes, Obesity & Metabolism; Nov2023, Vol. 25 Issue 11, p3079-3092, 14p

مصطلحات موضوعية: GLUCAGON-like peptide 1, REGULATION of body weight, GLYCEMIC control, HORMONE receptors, TYPE 2 diabetes, PEPTIDE receptors, CLINICAL trials

3

دورية أكاديمية

Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis.

المؤلفون: Tabák, Ádám G, Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J, Wysham, Carol, Meier, Juris J

مصطلحات موضوعية: Hypoglycemia, Insulin therapy, Type 2 diabetes, Weight control, iGlarLixi

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/14842Test; PMC6965545; https://link.springer.com/content/pdf/10.1007/s13300-019-00735-7.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965545/pdfTest

الإتاحة: https://doi.org/10.1007/s13300-019-00735-7Test
http://hdl.handle.net/10668/14842Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965545/pdfTest

View record in BASE

النص الكامل

4

دورية أكاديمية

Digestive, Anorectal, and Urogenital Functions in Patients with Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and Normal Glucose Tolerance: Association with Autonomic Neuropathy.

المؤلفون: Quast, Daniel R, Boronikolos, Georgios C, Menge, Bjoern A, Breuer, Thomas GK, Schenker, Nina, Meier, Juris J

المصدر: Experimental & Clinical Endocrinology & Diabetes; May2023, Vol. 131 Issue 5, p299-306, 8p

مصطلحات موضوعية: TYPE 2 diabetes, HEART beat, IRRITABLE colon, DYSAUTONOMIA, FECAL incontinence, NEUROPATHY, SMALL intestinal bacterial overgrowth

5

دورية أكاديمية

Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.

المؤلفون: Meier, Juris J.¹ (AUTHOR) juris.meier@rub.de, Bardtrum, Lars² (AUTHOR), Cheng, Alice Y. Y.³ (AUTHOR), Malling, Brian² (AUTHOR), Montanya, Eduard⁴ (AUTHOR), Wagner, Lily² (AUTHOR), Pratley, Richard E.⁵ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. Apr2023, Vol. 25 Issue 4, p1130-1135. 6p.

مصطلحات موضوعية: *WEIGHT loss, *TYPE 2 diabetes, *SEMAGLUTIDE, *BODY weight, *HEALTH services administration, *GLUCAGON-like peptide-1 receptor

6

دورية أكاديمية

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective.

المؤلفون: Laspe, Insa¹, Meier, Juris J.^2,3, Nauck, Michael A.^1,2 michael.nauck@rub.de

المصدر: Diabetes & Metabolism Journal. Jan2023, Vol. 47 Issue 1, p140-146. 7p.

مصطلحات موضوعية: *TYPE 2 diabetes, *TYPE 1 diabetes, *PEOPLE with diabetes, *INSULIN therapy

النص الكامل

7

دورية أكاديمية

Statistical power for MACE and individual secondary endpoints in cardiovascular outcomes trials for type 2 diabetes: a systematic review.

المؤلفون: Birker, Sebastian¹ (AUTHOR), Meier, Juris J.^1,2 (AUTHOR), Nauck, Michael A.¹ (AUTHOR) Michael.nauck@rub.de

المصدر: Scientific Reports. 12/6/2022, Vol. 12 Issue 1, p1-9. 9p.

مصطلحات موضوعية: *TYPE 2 diabetes, *LOG-rank test, *STATISTICAL power analysis, *MAJOR adverse cardiovascular events

النص الكامل

8

دورية أكاديمية

Measurement of Gastric Emptying Using a¹³ C-octanoic Acid Breath Test with Wagner-Nelson Analysis and Scintigraphy in Type 2 Diabetes.

المؤلفون: Trahair, Laurence G, Nauck, Michael A, Wu, Tongzhi, Stevens, Julie E, Buttfield, Madeline D, Hatzinikolas, Seva, Pham, Hung, Meier, Juris J, Rayner, Christopher K, Horowitz, Michael, Jones, Karen L

المصدر: Experimental & Clinical Endocrinology & Diabetes; Nov2022, Vol. 130 Issue 11, p751-757, 7p

مصطلحات موضوعية: GASTRIC emptying, TYPE 2 diabetes, BREATH tests, RADIONUCLIDE imaging, BODY mass index

9

دورية أكاديمية

Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.

المؤلفون: Aroda, Vanita R., Bauer, Robert, Christiansen, Erik, Haluzík, Martin, Kallenbach, Klaus, Montanya, Eduard, Rosenstock, Julio, Meier, Juris J.

المصدر: Diabetes, Obesity & Metabolism; Jul2022, Vol. 24 Issue 7, p1338-1350, 13p

10

دورية أكاديمية

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.

المؤلفون: Meier, Juris J.^1,2 (AUTHOR) juris.meier@ruhr-uni-bochum.de, Quast, Daniel R.¹ (AUTHOR), Nauck, Michael A.¹ (AUTHOR), Schenker, Nina¹ (AUTHOR), Deacon, Carolyn F.³ (AUTHOR), Holst, Jens J.³ (AUTHOR), Plum‐Mörschel, Leona⁴ (AUTHOR), Kapitza, Christoph⁵ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. May2022, Vol. 24 Issue 5, p806-815. 10p.

مصطلحات موضوعية: *SODIUM-glucose cotransporters, *GASTRIC inhibitory polypeptide, *TYPE 2 diabetes, *LINAGLIPTIN, *PEOPLE with diabetes, *CD26 antigen

تنقيح النتائج